Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 26/5/2020
SIETES contiene 93011 citas

 
 
<< anterior 21 a 40 de 117 siguiente >>
Presentar resultados
Seleccionar todas
21.Tiene citas relacionadas Cita con resumen
Huybrechts KF, Gerhard T, Crystal S, Olfson M, Avorn J, Levin R, Lucas JA, Schneeweiss S. Differential risk of death in older residents in nursing homes prescribed specific antipsychotic drugs: population based cohort study. BMJ 2012;344:16. [Ref.ID 92610]
22.Tiene citas relacionadas Cita con resumen
McCleery J, Fox R. Antipsychotic prescribing in nursing homes. BMJ 2012;344:7. [Ref.ID 92608]
23. Cita con resumen
Anónimo. Antipsychotics in children and adolescents: cardiometabolic reactions. Canada. WHO Drug Information 2012;26:29-30. [Ref.ID 92558]
24. Cita con resumen
Anónimo. Quetiapine (Seroquel) and QT-interval prolongation. Med Lett Drugs Ther 2011;53:79-80. [Ref.ID 91713]
25.
Mackin P, Thomas SHL. Atypical antipsychotic drugs. BMJ 2011;342:650-4. [Ref.ID 91242]
26. Cita con resumen
Maher AR, Maglione M, Bagley S, Suttorp M, Hu J-H, Ewing B, Wang Z, Timmer M, Sultzer D, Shekelle PG. Efficacy and comparative effectiveness of atypical antipsychotic medications for off-label uses in adults. A systematic review and meta-analysis. JAMA 2011;306:1359-69. [Ref.ID 91219]
27. Cita con resumen
Lambert T. Managing the metabolic adverse effects of antipsychotic drugs in patients with psychosis. Australian Prescriber 2011;34:97-9. [Ref.ID 91100]
28. Cita con resumen
Devi S. Report criticises antipsychotic use in US nursing homes. Lancet 2011;378:116. [Ref.ID 90864]
29. Cita con resumen
Anónimo. Lurasidone (Latuda) for schizophrenia. Med Lett Drugs Ther 2011;53:13-4. [Ref.ID 90241]
30. Cita con resumen
Stevens AJ, Jensen JJ, Wyller K, Kilgore PC, Chatterjee S, Rohrbaugh ML. The role of public-sector research in the discovery of drugs and vaccines. N Engl J Med 2011;364:535-41. [Ref.ID 90172]
31.
Frye MA. Bipolar disorder - A focus on depression. N Engl J Med 2011;364:51-9. [Ref.ID 90015]
32. Cita con resumen
Karouni M, Arulthas S, Larsson PG, Rytter E, Johannessen SI, Landmark CJ. Psychiatric comorbidity in patients with epilepsy: a population-based study. Eur J Clin Pharmacol 2010;66:1151-60. [Ref.ID 89587]
33.Tiene citas relacionadas
Varley C, McClellan J. Risks from antipsychotic medications in children and adolescents. In reply. JAMA 2010;303:730-1. [Ref.ID 87923]
34.Tiene citas relacionadas
Correll CU, Kane JM, Malhotra AK. Risks from antipsychotic medications in children and adolescents. In reply. JAMA 2010;303:730. [Ref.ID 87922]
35.Tiene citas relacionadas Cita con resumen
Lewin AB, Stroch EA, Storch HD. Risks from antipsychotic medications in children and adolescents. JAMA 2010;303:729-30. [Ref.ID 87921]
36.Tiene citas relacionadas Cita con resumen
Mangurian C, Fuentes-Afflick E, Newcomer JW. Risks from antipsychotic medications in children and adolescents. JAMA 2010;303:729. [Ref.ID 87920]
38.Tiene citas relacionadas Cita con resumen
Correll CU, Manu P, Olshanskiy V, Napolitano B, Kane JM, Malhotra AK. Cardiometabolic risk of second-generation antipsychotic medications during first-time use in children and adolescents. JAMA 2009;302:1765-73. [Ref.ID 86924]
40.
Van Os J, Kapur S. Schizophrenia. Lancet 2009;374:635-45. [Ref.ID 86639]
Seleccionar todas
 
<< anterior 21 a 40 de 117 siguiente >>